Nursing Home Antipsychotic Misuse: False Diagnoses and Resident Risk

A recent report from the Department of Health and Human Services (HHS) Office of Inspector General (OIG) has revealed alarming instances of inappropriate antipsychotic drug use in nursing homes, coupled with evidence suggesting facilities are misdiagnosing patients with schizophrenia to justify the medications. The findings raise serious concerns about resident safety and the quality of care within the long-term care system.

Widespread Inappropriate Prescriptions

The OIG’s comprehensive review of 40 focused nursing home inspections conducted by the Centers for Medicare & Medicaid Services (CMS) uncovered a pattern of antipsychotic drugs being administered to residents with dementia to manage behavioral issues, often for the convenience of staff. This practice is particularly troubling as the Food and Drug Administration (FDA) has warned that antipsychotic drugs can increase the risk of death for individuals with dementia. [1]

Masking Misuse with False Diagnoses

The OIG report indicates that some nursing homes are improperly diagnosing residents with schizophrenia – a condition requiring a different treatment approach – to mask the inappropriate use of antipsychotic drugs. [4] This practice allows facilities to appear to be providing medically necessary care whereas potentially sedating patients unnecessarily.

Systemic Failures in Oversight

The report highlights several systemic failures contributing to the problem:

• Medical Directors: Failed to prevent the inappropriate use of antipsychotic drugs.
• Pharmacists: Did not identify medical concerns or recommend dose reductions.
• Policies and Procedures: Inadequate nursing home policies and procedures undermined safeguards meant to protect residents. [1]

CMS Response and Ongoing Review

The Centers for Medicare and Medicaid Services (CMS) has acknowledged the concerns and stated it is “actively” reviewing federal rules on antipsychotic use in nursing homes. [2] This review aims to support clinically appropriate use while discouraging misuse, following a recent update designed to improve reporting accuracy.

OIG Recommendations

The OIG has recommended that CMS further develop resources for nursing homes and increase transparency to reduce the inappropriate use of antipsychotic drugs and improve dementia care. [1]

Looking Ahead

This report underscores the urgent need for increased oversight and improved safeguards to protect vulnerable residents in nursing homes. The ongoing CMS review and the OIG’s recommendations represent important steps toward addressing this critical issue and ensuring that antipsychotic medications are used responsibly and ethically. [3]